https://www.ncbi.nlm.nih.gov/Structure/pdb/5F1L
5F1L: Crystal structure of the bromodomain of BRD9 in complex with compound 9
Bromodomain-containing protein 95-[3,5-dimethoxy-4-[(3-oxidanylazetidin-1-yl)methyl]phenyl]-1,3-dimethyl-pyridin-2-one
crystal structureof the
https://www.rcsb.org/structure/5IGN
RCSB PDB - 5IGN: Crystal structure of human BRD9 bromodomain in complex with LP99 chemical probe
Crystal structure of human BRD9 bromodomain in complex with LP99 chemical probe
https://www.ncbi.nlm.nih.gov/Structure/pdb/6Y7J
6Y7J: Structure of the BRD9 bromodomain and compound 15
Bromodomain-containing protein 91-[8-(2,5-dimethoxyphenyl)pyrrolo[1,2-a]pyrimidin-6-yl]ethanone
of thestructurebrd9bromodomaincompound
https://www.ncbi.nlm.nih.gov/Structure/pdb/4Z6I
4Z6I: Crystal structure of BRD9 bromodomain in complex with a substituted valerolactam quinolone...
Bromodomain-containing protein 9tert-butyl [(2R,3S)-1-(1,4-dimethyl-2-oxo-1,2-dihydroquinolin-7-yl)-6-oxo-2-phenylpiperidin-3-yl]carbamate
https://www.biospace.com/rumi-scientific-announces-data-demonstrating-disease-modifying-effect-of-brd9-inhibition-in-a-huntington-s-disease-animal-model
Rumi Scientific Announces Data Demonstrating Disease Modifying Effect of BRD9 Inhibition in a...
Apr 26, 2023 - Rumi Scientific announced data demonstrating in vivo proof of concept of a disease modifying effect of bromodomain protein 9 (BRD9) inhibition as a potential...
https://www.rcsb.org/structure/6V14
RCSB PDB - 6V14: Crystal structure of the bromodomain of human BRD9 bound to TP472
Crystal structure of the bromodomain of human BRD9 bound to TP472